Business
First Sigma, then the world – CWH plans for domination
Chemist Warehouse’s owners are focused on making the Australian discounter the world’s number-one pharmacy franchise as part of 100-year plan Merging with pharmaceutical wholesaler, Sigma Healthcare, is part of Chemist …
Amcal, DDS franchisees to benefit from CWH ‘know how’
Sigma Healthcare franchisees to gain access to Chemist Warehouse’s IP under proposed merger Plans to create a $8.8 billion healthcare powerhouse through the merger of Sigma Healthcare and Chemist Warehouse …
Whale swallows minnow; the Sigma CWH reverse takeover
“Historic and creative” $8b deal machinations go back at least 18 months. How will it change pharmacy? When Sigma Healthcare’s shares suddenly went into a trading halt this past Wednesday …
Guild slams CWH-Sigma takeover with ‘increased commercialisation’ warning
The Pharmacy Guild of Australia says it believes the “apparent imminent takeover” of Sigma Healthcare by Chemist Warehouse poses significant questions and risks The Pharmacy Guild has responded to yesterday’s …
CWH in ASX reverse listing?
Sigma Healthcare announces a halt in trading, as a move which could see a reverse listing of Chemist Warehouse on the ASX is reportedly finalised Sigma Healthcare Limited securities have …
Fewer Aussies visiting pharmacies: NAB
Australia’s most accessible health professionals are being visited by fewer patients, bank reports New data from NAB’s Health Insights Report shows 61% of Australians have visited a pharmacy in the …
Supply shortages continue to challenge pharmacies
Pharmacy staff are being forced to deal with medicines shortages, with 60-day dispensing not making life any easier, pharmacist warns Suggestions from Department of Health and Aged Care bureaucrats, that …
Charac investment to boost MedAdvisor platform
Strategic deal to enhance the capabilities of MedAdvisor Solutions’ Plus One platform, while generating significant savings Australian Securities Exchange (ASX) listed medication management platform provider, MedAdvisor, is set to invest …
AFT sees 24% hike in sales
Flagship Maxigesic products and Australian OTC business contribute the most to latest half yearly results Maxigesic manufacturer AFT Pharmaceuticals has reported higher bottom-line profit and revenue after continued robust demand …
